These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease. Lovisa S; Genovese G; Danese S J Crohns Colitis; 2019 Apr; 13(5):659-668. PubMed ID: 30520951 [TBL] [Abstract][Full Text] [Related]
8. Role of non-inflammatory factors in intestinal fibrosis. Zhao JF; Ling FM; Li JR; Chen YD; Huang L; Zhu LR J Dig Dis; 2020 Jun; 21(6):315-318. PubMed ID: 32406603 [TBL] [Abstract][Full Text] [Related]
9. Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science. Rieder F; Fiocchi C Curr Opin Gastroenterol; 2008 Jul; 24(4):462-8. PubMed ID: 18622160 [TBL] [Abstract][Full Text] [Related]
10. Features of intestinal lesions in the clinical course of inflammatory bowel diseases. Vetuschi A; Latella G; Pompili S; Gaudio E; Sferra R Ital J Anat Embryol; 2014; 119(3):286-303. PubMed ID: 26749690 [TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease. Stewart DC; Berrie D; Li J; Liu X; Rickerson C; Mkoji D; Iqbal A; Tan S; Doty AL; Glover SC; Simmons CS PLoS One; 2018; 13(7):e0200377. PubMed ID: 29995938 [TBL] [Abstract][Full Text] [Related]
12. Preventing fibrosis in IBD: update on immune pathways and clinical strategies. Wang J; Yang B; Chandra J; Ivanov A; Brown JM; Rieder F Expert Rev Clin Immunol; 2024 Jul; 20(7):727-734. PubMed ID: 38475672 [TBL] [Abstract][Full Text] [Related]
13. New therapeutic avenues for treatment of fibrosis: can we learn from other diseases? Rogler G Dig Dis; 2014; 32 Suppl 1():39-49. PubMed ID: 25531352 [TBL] [Abstract][Full Text] [Related]